Audrey D. Zhang

530 total citations
19 papers, 291 citations indexed

About

Audrey D. Zhang is a scholar working on Economics and Econometrics, Pharmacology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Audrey D. Zhang has authored 19 papers receiving a total of 291 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Economics and Econometrics, 5 papers in Pharmacology and 4 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Audrey D. Zhang's work include Pharmaceutical Economics and Policy (9 papers), Health Systems, Economic Evaluations, Quality of Life (8 papers) and Statistical Methods in Clinical Trials (4 papers). Audrey D. Zhang is often cited by papers focused on Pharmaceutical Economics and Policy (9 papers), Health Systems, Economic Evaluations, Quality of Life (8 papers) and Statistical Methods in Clinical Trials (4 papers). Audrey D. Zhang collaborates with scholars based in United States and Canada. Audrey D. Zhang's co-authors include Joseph S. Ross, Joshua D. Wallach, Harlan M. Krumholz, Jeremy Puthumana, Nilay D. Shah, Nicholas S. Downing, Jason L. Schwartz, Sanket S. Dhruva, Haiqun Lin and Kun Wang and has published in prestigious journals such as JAMA, Annals of Internal Medicine and BMJ.

In The Last Decade

Audrey D. Zhang

16 papers receiving 284 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Audrey D. Zhang United States 10 145 50 49 39 36 19 291
Giovanni Tafuri Italy 12 277 1.9× 45 0.9× 56 1.1× 41 1.1× 21 0.6× 22 463
Birgitta Grundmark Sweden 13 66 0.5× 36 0.7× 30 0.6× 21 0.5× 113 3.1× 18 593
Roberta Joppi Italy 10 326 2.2× 59 1.2× 23 0.5× 28 0.7× 24 0.7× 20 451
Tiffany S. Woodworth United States 8 73 0.5× 15 0.3× 20 0.4× 64 1.6× 39 1.1× 14 367
Alexander C. Egilman United States 10 164 1.1× 33 0.7× 37 0.8× 23 0.6× 19 0.5× 22 290
Ashlyn Pinto Canada 5 262 1.8× 26 0.5× 22 0.4× 59 1.5× 26 0.7× 10 430
P Chan United Kingdom 5 34 0.2× 39 0.8× 21 0.4× 58 1.5× 47 1.3× 6 294
Catherine I. Starner United States 9 160 1.1× 33 0.7× 16 0.3× 7 0.2× 34 0.9× 15 345
Marisa Papaluca‐Amati Netherlands 10 75 0.5× 106 2.1× 50 1.0× 87 2.2× 53 1.5× 11 395
Stéphane Lejeune Belgium 10 54 0.4× 32 0.6× 15 0.3× 27 0.7× 23 0.6× 15 334

Countries citing papers authored by Audrey D. Zhang

Since Specialization
Citations

This map shows the geographic impact of Audrey D. Zhang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Audrey D. Zhang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Audrey D. Zhang more than expected).

Fields of papers citing papers by Audrey D. Zhang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Audrey D. Zhang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Audrey D. Zhang. The network helps show where Audrey D. Zhang may publish in the future.

Co-authorship network of co-authors of Audrey D. Zhang

This figure shows the co-authorship network connecting the top 25 collaborators of Audrey D. Zhang. A scholar is included among the top collaborators of Audrey D. Zhang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Audrey D. Zhang. Audrey D. Zhang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Zhang, Audrey D., Lindsay Zepel, Sandra Woolson, et al.. (2024). Initiation and Persistence of Antipsychotic Medications at Hospital Discharge Among Community-Dwelling Veterans With Dementia. American Journal of Geriatric Psychiatry. 33(5). 500–511.
2.
Pavon, Juliessa M., Audrey D. Zhang, Laura J. Fish, et al.. (2024). Factors influencing central nervous system medication deprescribing and behavior change in hospitalized older adults. Journal of the American Geriatrics Society. 72(8). 2359–2371. 1 indexed citations
3.
Rowhani-Farid, Anisa, Allen O. Eghrari, Audrey D. Zhang, et al.. (2023). Clinical trial data sharing: a cross-sectional study of outcomes associated with two U.S. National Institutes of Health models. Scientific Data. 10(1). 529–529. 3 indexed citations
4.
Zhang, Audrey D., Timothy S. Anderson, & Susan N. Hastings. (2023). Demographic characteristics of participants in clinical trials to treat Alzheimer disease, 2008–2023. Journal of the American Geriatrics Society. 72(3). 942–945.
5.
Rowhani-Farid, Anisa, et al.. (2022). Consistency between trials presented at conferences, their subsequent publications and press releases. BMJ evidence-based medicine. 28(2). 95–102. 4 indexed citations
6.
Zhang, Audrey D. & Timothy S. Anderson. (2022). Comparison of Industry Payments to Physicians and Advanced Practice Clinicians. JAMA. 328(24). 2452–2452. 11 indexed citations
7.
Zhang, Audrey D., et al.. (2021). US Food and Drug Administration utilization of postmarketing requirements and postmarketing commitments, 2009–2018. Clinical Trials. 18(4). 488–499. 19 indexed citations
8.
Wallach, Joshua D., Audrey D. Zhang, Victoria Bartlett, et al.. (2021). Feasibility of Using Real-world Data to Emulate Postapproval Confirmatory Clinical Trials of Therapeutic Agents Granted US Food and Drug Administration Accelerated Approval. JAMA Network Open. 4(11). e2133667–e2133667. 19 indexed citations
9.
Dhodapkar, Meera M., Audrey D. Zhang, Jeremy Puthumana, et al.. (2021). Characteristics of Clinical Studies Used for US Food and Drug Administration Supplemental Indication Approvals of Drugs and Biologics, 2017 to 2019. JAMA Network Open. 4(6). e2113224–e2113224. 19 indexed citations
10.
Egilman, Alexander C., Joshua D. Wallach, Jeremy Puthumana, et al.. (2021). Characteristics of Preapproval and Postapproval Studies of Vaccines Granted Accelerated Approval by the US Food and Drug Administration. Journal of General Internal Medicine. 36(10). 3281–3284.
11.
Zhang, Audrey D., et al.. (2021). Evaluation of Trials Comparing Single-Enantiomer Drugs to Their Racemic Precursors. JAMA Network Open. 4(5). e215731–e215731. 13 indexed citations
12.
Wallach, Joshua D., Jennifer Miller, Audrey D. Zhang, et al.. (2021). Reporting of Study Participant Demographic Characteristics and Demographic Representation in Premarketing and Postmarketing Studies of Novel Cancer Therapeutics. JAMA Network Open. 4(4). e217063–e217063. 24 indexed citations
13.
Puthumana, Jeremy, Alexander C. Egilman, Audrey D. Zhang, Jason L. Schwartz, & Joseph S. Ross. (2020). Speed, Evidence, and Safety Characteristics of Vaccine Approvals by the US Food and Drug Administration. JAMA Internal Medicine. 181(4). 559–559. 14 indexed citations
14.
Zhang, Audrey D., et al.. (2020). Disagreements Within the US Food and Drug Administration Regarding Approval of Novel Therapeutic Agents, 2011-2015. JAMA Network Open. 3(7). e209498–e209498. 5 indexed citations
15.
Wallach, Joshua D., Kun Wang, Audrey D. Zhang, et al.. (2020). Updating insights into rosiglitazone and cardiovascular risk through shared data: individual patient and summary level meta-analyses. BMJ. 368. l7078–l7078. 62 indexed citations
16.
Zhang, Audrey D., Jeremy Puthumana, Nicholas S. Downing, et al.. (2020). Assessment of Clinical Trials Supporting US Food and Drug Administration Approval of Novel Therapeutic Agents, 1995-2017. JAMA Network Open. 3(4). e203284–e203284. 74 indexed citations
17.
Zhang, Audrey D. & Joseph S. Ross. (2019). Biomarkers as Surrogate Endpoints: Ongoing Opportunities for Validation. The Journal of Law Medicine & Ethics. 47(3). 393–395. 2 indexed citations
18.
Egilman, Alexander C., Audrey D. Zhang, Joshua D. Wallach, & Joseph S. Ross. (2019). Medicare Part D Spending on Single-Enantiomer Drugs Versus Their Racemic Precursors. Annals of Internal Medicine. 171(7). 521–523. 4 indexed citations
19.
Zhang, Audrey D., Jason L. Schwartz, & Joseph S. Ross. (2019). Association Between Food and Drug Administration Advisory Committee Recommendations and Agency Actions, 2008–2015. Milbank Quarterly. 97(3). 796–819. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Giovanni Tafuri Breakdown of academic impact, for papers by Birgitta Grundmark Breakdown of academic impact, for papers by Roberta Joppi Breakdown of academic impact, for papers by Tiffany S. Woodworth Breakdown of academic impact, for papers by Alexander C. Egilman Breakdown of academic impact, for papers by Ashlyn Pinto Breakdown of academic impact, for papers by P Chan Breakdown of academic impact, for papers by Catherine I. Starner Breakdown of academic impact, for papers by Marisa Papaluca‐Amati Breakdown of academic impact, for papers by Stéphane Lejeune
Rankless by CCL
2026